The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

David E. Kandzari

Duke Clinical Research Institute

Durham

North Carolina 27705

USA

[email]@duke.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Duke Clinical Research Institute, Durham, North Carolina 27705, USA. 2005 - 2006
  • Department of Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, USA. 2006

References

  1. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. Kandzari, D.E., Kiesz, R.S., Allie, D., Walker, C., Fail, P., Ramaiah, V.G., Cardenas, J., Vale, J., Chopra, A., Gammon, R.S. J. Endovasc. Ther. (2006) [Pubmed]
  2. Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting. Kandzari, D.E., Tuttle, R.H., Zidar, J.P., Jollis, J.G. Am. J. Cardiol. (2006) [Pubmed]
  3. Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction. Kandzari, D.E., Tcheng, J.E., Gersh, B.J., Cox, D.A., Stuckey, T., Turco, M., Mehran, R., Garcia, E., Zimetbaum, P., McGlaughlin, M.G., Lansky, A.J., Costantini, C.O., Grines, C.L., Stone, G.W. Am. Heart J. (2006) [Pubmed]
  4. Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent. Kandzari, D.E., Leon, M.B. J. Interv. Cardiol (2006) [Pubmed]
  5. Drug-eluting stent thrombosis: it's never too late. Kandzari, D.E. Nature Clinical Practice. Cardiovascular Medicine (2006) [Pubmed]
  6. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. Kandzari, D.E., Leon, M.B., Popma, J.J., Fitzgerald, P.J., O'Shaughnessy, C., Ball, M.W., Turco, M., Applegate, R.J., Gurbel, P.A., Midei, M.G., Badre, S.S., Mauri, L., Thompson, K.P., LeNarz, L.A., Kuntz, R.E. J. Am. Coll. Cardiol. (2006) [Pubmed]
  7. Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes. Kandzari, D.E., Roe, M.T., Chen, A.Y., Lytle, B.L., Pollack, C.V., Harrington, R.A., Ohman, E.M., Gibler, W.B., Peterson, E.D. Am. Heart J. (2005) [Pubmed]
  8. Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes. Kandzari, D.E., Roe, M.T., Ohman, E.M., Milford-Beland, S., Chen, A.Y., Lytle, B.L., Cohen, D.J., Smith, S.C., Harrington, R.A., Gibler, W.B., Peterson, E.D. Am. J. Cardiol. (2005) [Pubmed]
 
WikiGenes - Universities